Literature DB >> 24423330

Growth patterns of pituitary adenomas and histopathological correlates.

Eric Monsalves1, Soroush Larjani, Bruno Loyola Godoy, Kyle Juraschka, Felipe Carvalho, Walter Kucharczyk, Abhaya Kulkarni, Ozgur Mete, Fred Gentili, Shereen Ezzat, Gelareh Zadeh.   

Abstract

CONTEXT: The factors associated with pituitary adenoma (PA) growth rate remain unclear.
OBJECTIVE: The objective of the study was to establish whether the preoperative growth and extension pattern of PA can predict postoperative growth rate and recurrence in addition to whether the PA growth rate correlates with proliferation and growth factor expression. PATIENTS: One hundred fifty-three consecutive patients who underwent surgery for pituitary adenoma from 1999 to 2011 at Toronto Western Hospital were identified. MAIN OUTCOME MEASURES: The PA growth rate was measured both pre- and postoperatively, and its association with patient demographics, magnetic resonance imaging, and histolopathological parameters was determined.
RESULTS: The preoperative growth rate was associated with age (P = .0001), suprasellar growth (P = .003), the presence of a cyst/hemorrhage (P = .004), the mindbomb homolog-1 (P = .005), fibroblast growth factor receptor-4 positivity (P = .047), and p27 negativity (P = .007). After surgery, there were 34.6% residual volumes, which were associated with older age (P = .038) and also with growth patterns including anterior, posterior, suprasellar, and cavernous sinus extension (P = .001); 43.3% of these residuals grew and postoperative growth rate was calculated. Pre- and postoperative growth rates were correlated (r = 0.497, P = .026). Postoperative growth rate was associated with age (P = .015) and gender (P = .017).
CONCLUSIONS: Our data suggest that the growth rate of PAs are influenced by various patient- and tumor-specific characteristics including the age and sex of the patient, the specific subtype of PA, its hormonal activity, its immunohistochemical profile including the mindbomb homolog 1 labeling index status, and its preponderance for different growth directions relative to the pituitary fossa. Furthermore, the pre- and postoperative PA growth rates were correlated, suggesting that postoperative PA growth rates can be predicted, in part, by preoperative growth rates, thus better informing postoperative outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24423330     DOI: 10.1210/jc.2013-3054

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.

Authors:  James A Balogun; Eric Monsalves; Kyle Juraschka; Kashif Parvez; Walter Kucharczyk; Ozgur Mete; Fred Gentili; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

Review 2.  Prognostic factors of regrowth in nonfunctioning pituitary tumors.

Authors:  Gerald Raverot; Alexandre Vasiljevic; Emmanuel Jouanneau
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

3.  Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.

Authors:  Kristin Astrid Øystese; Manuela Zucknick; Olivera Casar-Borota; Geir Ringstad; Jens Bollerslev
Journal:  Endocrine       Date:  2017-05-17       Impact factor: 3.633

Review 4.  Non-functioning pituitary adenomas: growth and aggressiveness.

Authors:  Kristin Astrid Øystese; Johan Arild Evang; Jens Bollerslev
Journal:  Endocrine       Date:  2016-04-11       Impact factor: 3.633

Review 5.  Aggressive pituitary adenomas--diagnosis and emerging treatments.

Authors:  Antonio Di Ieva; Fabio Rotondo; Luis V Syro; Michael D Cusimano; Kalman Kovacs
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

Review 6.  Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Authors:  Ashley B Grossman; Shereen Ezzat; Sylvia L Asa; Ozgur Mete; Michael D Cusimano; Ian E McCutcheon; Arie Perry; Shozo Yamada; Hiroshi Nishioka; Olivera Casar-Borota; Silvia Uccella; Stefano La Rosa
Journal:  Mod Pathol       Date:  2021-05-21       Impact factor: 7.842

7.  Macroprolactinoma appearing after resolution of hydrocephalus.

Authors:  Oscar D Bruno; Ricardo Fernández Pisani; Gabriel Isaac; Armando Basso
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-04-19

8.  Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.

Authors:  Xiaohui Yao; Hua Gao; Chuzhong Li; Lijuan Wu; Jiwei Bai; Jichao Wang; Yangfang Li; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2017-03-02       Impact factor: 4.130

9.  Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis.

Authors:  Jian-Qi Xiao; Xiao-Hai Liu; Bo Hou; Yong Yao; Kan Deng; Min Feng; Bin Xing; Wei Lian; Ren-Zhi Wang; Feng Feng
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

Review 10.  The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-10-29       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.